Created On: 2020-07-15
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 203467
For the call option, Assignee shall have the option, until sixty (60) Business Days after the Interim Analysis Date, to include the Republic of China in the Territory by having the Call Option Letter signed and executed by Assignor.
Assignee shall have the exclusive right under the Assigned Technology and the Product Trademarks to market, sell, offer to sell, use, import and export, distribute and license Products in the Territory, and submit for approval for or amendment of Marketing Authorization for the Product in the Territory.
For Assignees manufacturing rights, beginning at the earlier of three (3) years from the date of the First Commercial Sale in the Territory or Assignorâ€™s breach of its obligations of supply of Product, in a period exceeding 2 months, Assignee shall have the exclusive right to manufacture, or have manufactured, Product for use in the Territory.
For the Dossier, the Dossier(s) shall be the sole property of Assignee, and Assignor hereby assigns by way of future assignment any rights in or to any amendments or modifications to, or translations of, the Dossiers which it may affect or which may be affected on its behalf, in connection with its use of the Dossiers under the terms of this Agreement; provided, however, that Assignor shall have reasonable access to and use of the Dossiers for Assignorâ€™s use in seeking Marketing Authorizations outside the Territory.
Assignor hereby grants to Assignee a non-exclusive right and license to reference any Marketing Authorizations under the control of Assignor for Products outside the Territory for the purpose of obtaining Marketing Authorization of Products in one or more countries in the Territory.
Assignee shall own all rights in Dossiers, Marketing Authorizations in the Territory, Product and Scientific Data, and the information and data contained therein.
The Product means all injectable fluorochemical emulsions capable of transporting oxygen in therapeutic effective amounts in the bloodstream for all medical uses, including without limitation, a product existing as of the Effective Date having a composition agreed upon by the Parties and set out in the Specifications, Existing Product, that the making, using, offering for sale, or selling of which without a license or assignment would infringe a Valid Claim of a patent within the Assigned Patents, is developed using the Assigned Technology, and/or is a modification or change in the formula of the Existing Product.
The patents include: Brominated Perfluorocarbon Emulsions for Internal Animal Use for Contrast Enhancement and Oxygen Transport/ LONG, and, AmphAssigned Technologyhilic Fluorine Derivatives with Telomeric Structures; Preparation Procedure and Biomedical Applications / PA VIA, PUCCI, RlESS, ZARIF, and related foreign patents.
OXYGENT (perflubron emulsion) is an intravascular oxygen delivery agent to temporarily augment oxygen delivery in surgical and other patients at risk of acute tissue oxygen deficit. It will be used as a temporary oxygen carrier to provide oxygen to tissues during elective surgeries where substantial blood loss is anticipate.
IPSCIO Record ID: 1451
IPSCIO Record ID: 3608
Product shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered in whole or in part by a Valid Claim contained in any Patent.
IPSCIO Record ID: 738